According to studies, BuChE activity is greatly increased (41–80%) in the brains of people with advanced AD, particularly in areas affected by Aβ plaques and neurofibrillary tangles (NFT), in contrast to a 10–60% AChE deficit [10]. The gene discussed is ACHE; the disease is Alzheimer disease.